|
ZNF658 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.9401039642637E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.39720013336841E-10 |
| Normal-vs-Stage2 |
1.69882999999649E-05 |
| Normal-vs-Stage3 |
1.12400089236075E-11 |
| Normal-vs-Stage4 |
1.7036372312873E-12 |
| Stage1-vs-Stage2 |
6.812300E-02 |
| Stage1-vs-Stage3 |
1.119360E-01 |
| Stage1-vs-Stage4 |
2.225200E-04 |
| Stage2-vs-Stage3 |
1.149630E-02 |
| Stage2-vs-Stage4 |
2.435900E-04 |
| Stage3-vs-Stage4 |
4.783700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.96980209921094E-11 |
| Normal-vs-AfricanAmerican |
1.38660000148505E-08 |
| Normal-vs-Asian |
6.34930000020795E-07 |
| Caucasian-vs-AfricanAmerican |
6.640600E-01 |
| Caucasian-vs-Asian |
6.066400E-02 |
| AfricanAmerican-vs-Asian |
1.324430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.25160001754432E-10 |
| Normal-vs-Female |
4.5592973840769E-11 |
| Male-vs-Female |
5.454400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.72110112220503E-11 |
| Normal-vs-Age(41-60Yrs) |
8.33569879787888E-11 |
| Normal-vs-Age(61-80Yrs) |
2.40149999886086E-09 |
| Normal-vs-Age(81-100Yrs) |
7.410100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.864000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.131400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.950400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.431000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.566800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.013200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.76809999996586E-06 |
| Classical-VS-Follicular |
6.644000E-04 |
| Classical-VS-Other |
6.645200E-01 |
| Classical-VS-Normal |
6.86419809881045E-11 |
| Tall-VS-Follicular |
8.08970002097453E-10 |
| Tall-VS-Other |
3.171400E-01 |
| Tall-VS-Normal |
1.63369318073592E-12 |
| Follicular-VS-Other |
1.625450E-01 |
| Follicular-VS-Normal |
9.4389000004913E-07 |
| Other-VS-Normal |
2.075300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62699997918736E-09 |
| Normal-vs-N1 |
1.87549975549928E-12 |
| N0-vs-N1 |
6.00229999999646E-05 |
|
|
